Management of Left Lower Quadrantanopia Sensory Deficit

Diagnostic Evaluation

The American College of Radiology recommends brain MRI with and without contrast as the primary diagnostic imaging modality for patients with left lower quadrantanopia, as this visual field defect typically indicates a lesion affecting the post-chiasmal visual pathway in the right occipital lobe 1
MRI of the brain without and with contrast is the preferred initial imaging modality for patients with homonymous quadrantanopia, as the defect is most likely in a post-chiasm location 1
If a vascular lesion is suspected, additional vascular imaging may be indicated, including MRA or CTA to provide information about potential vascular malformations or aneurysms 1
DSA may be considered if there is high suspicion for vascular pathology despite normal MRA/CTA 2, 3

Management should be directed toward the underlying etiology identified on imaging, according to the American Academy of Ophthalmology 2, 3
For vascular causes, acute stroke management may include consideration of thrombolytic therapy if within the appropriate time window, as recommended by the American College of Emergency Physicians 4
For tumors, surgical resection may be indicated depending on tumor type, location, and patient factors, with the goal of removing as much tumor tissue as safely feasible without compromising neurological function, as suggested by the National Comprehensive Cancer Network 5
Post-surgical MRI should be performed within 24-48 hours to assess extent of resection, as recommended by the National Comprehensive Cancer Network 5

Unlike diplopia management, prisms are generally not helpful for homonymous field defects, according to the American Academy of Ophthalmology 6
Visual rehabilitation options may include visual field awareness training and compensatory scanning strategies to improve awareness of the affected visual field, as recommended by the American Academy of Ophthalmology 7

Regular follow-up with visual field testing to monitor for any changes in the visual field defect is recommended by the American Academy of Ophthalmology 7
Periodic neuroimaging may be indicated based on the underlying etiology, as suggested by the American College of Radiology 1
Patients should be educated about potential symptoms that would warrant urgent reassessment, such as worsening visual field defect or new neurological symptoms, according to the American Academy of Ophthalmology 7